Press releases
- Encompass Health announces Andrew Baird as senior vice president of public policy, legislation and regulations
- Encompass Health and Piedmont announce plans to build a 40-bed inpatient rehabilitation hospital in Loganville, Georgia
- Encompass Health to present at Barclays Global Healthcare Conference
- Encompass Health declares dividend on common stock
- Encompass Health announces preliminary plans to build a 60-bed inpatient rehabilitation hospital in Avondale, Arizona
- Encompass Health reports results for fourth quarter 2023 and issues 2024 guidance
- Encompass Health Corp. Named One of the World's Most Admired Companies in 2024 by Fortune
- Encompass Health announces date of 2023 fourth quarter earnings call
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 71.00 |
---|---|
High | 71.00 |
Low | 70.50 |
Bid | 73.00 |
Offer | 75.00 |
Previous close | 70.50 |
Average volume | 0.80 |
---|---|
Shares outstanding | 100.14m |
Free float | 98.27m |
P/E (TTM) | 21.78 |
Market cap | 7.78bn USD |
EPS (TTM) | 3.57 USD |
Annual div (ADY) | 0.5541 EUR |
---|---|
Annual div yield (ADY) | 0.79% |
Div ex-date | Mar 28 2024 |
Div pay-date | Apr 15 2024 |
Data delayed at least 15 minutes, as of Mar 28 2024 07:32 BST.
More ▼